Cargando…

Identification of a robust functional subpathway signature for pancreatic ductal adenocarcinoma by comprehensive and integrated analyses

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy and its mortality continues to rise globally. Because of its high heterogeneity and complex molecular landscapes, published gene signatures have demonstrated low specificity and robustness. Functional signatures contai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ping, Zhang, Chunlong, Li, Weidong, Zhai, Bo, Jiang, Xian, Reddy, Shiva, Jiang, Hongchi, Sun, Xueying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053133/ https://www.ncbi.nlm.nih.gov/pubmed/32122386 http://dx.doi.org/10.1186/s12964-020-0522-4

Ejemplares similares

Comprehensive analysis of mRNA‐level and miRNA‐level subpathway activities for identifying robust ovarian cancer prognostic signatures
por: Tian, Songyu, et al.
Publicado: (2020)

Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma
por: Zhang, Chunlong, et al.
Publicado: (2022)

Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses
por: Zhang, Chunlong, et al.
Publicado: (2017)

Characterizing the Network of Drugs and Their Affected Metabolic Subpathways
por: Li, Chunquan, et al.
Publicado: (2012)

Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways
por: Li, Chunquan, et al.
Publicado: (2013)

Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma
por: Gu, Wenchao, et al.
Publicado: (2022)

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019)

Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies
por: Feng, Li, et al.
Publicado: (2015)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
por: Shi, Xinrui, et al.
Publicado: (2016)

Identification and Functional Analysis of Individual-Specific Subpathways in Lung Adenocarcinoma
por: Fang, Jingya, et al.
Publicado: (2022)

Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy
por: Chang, Huijuan, et al.
Publicado: (2018)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme
por: Han, Xudong, et al.
Publicado: (2020)

LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies
por: Xu, Yanjun, et al.
Publicado: (2017)

sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses
por: Zhang, Chun-Long, et al.
Publicado: (2017)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments
por: Pérez-Díez, Irene, et al.
Publicado: (2023)

Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
por: Han, Junwei, et al.
Publicado: (2018)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
por: Schnipper, Julie, et al.
Publicado: (2020)

ce‐Subpathway: Identification of ceRNA‐mediated subpathways via joint power of ceRNAs and pathway topologies
por: Feng, Chenchen, et al.
Publicado: (2018)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma
por: Tan, Daniel J., et al.
Publicado: (2020)

Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients
por: Ju, Jie, et al.
Publicado: (2021)

An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma
por: Liu, Shuguang, et al.
Publicado: (2023)

SubpathwayMiner: a software package for flexible identification of pathways
por: Li, Chunquan, et al.
Publicado: (2009)

MiRNA-Mediated Subpathway Identification and Network Module Analysis to Reveal Prognostic Markers in Human Pancreatic Cancer
por: Liu, Yuejuan, et al.
Publicado: (2020)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
por: Shao, Feng, et al.
Publicado: (2018)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
por: Ren, Min, et al.
Publicado: (2023)

Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma
por: Mascharak, Shamik, et al.
Publicado: (2023)

Homologous Recombination Subpathways: A Tangle to Resolve
por: Elbakry, Amira, et al.
Publicado: (2021)

Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses
por: LONG, JIN, et al.
Publicado: (2016)

Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Publicado: (2018)

Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
por: Elbanna, Khaled Y., et al.
Publicado: (2020)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma
por: Li, Ang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pd7djdt0fdu7pbuj05qhea6411